Rendia improves practice efficiency and adoption of premium services
The Care Journey
A new therapeutic approach for ptosis Until recently, there were few treatment options besides surgery for patients with ptosis, also known as blepharoptosis or drooping eyelids. That changed in 2020 when the FDA approved Upneeq eye drops (oxymetazoline HCL 1%),...
A huge population of patients are in need of presbyopia solutions There is an eye condition that will affect 100% of people at some point, yet the majority of patients don’t know what it’s called and aren’t satisfied with the main solution for it. A survey found...
Sign up for Rendia Connection
Your biweekly roundup of practice pearls to grow your business and create patients for life